Phase Space AI

Financial Model Notes

ServiceNow [NOW]

ServiceNow [NOW] — Financial Model Notes & Defect Log

As of 2026-07-29. Sources: Alpha Vantage normalized statements (64 quarterly periods), the Q2 2026 10-Q (0001373715-26-000076, filed 2026-07-23), the Q2 2026 earnings release 8-K (0001373715-26-000072, erq2fy26.htm, filed 2026-07-22), nine EARNINGS_CALL_TRANSCRIPT pulls, and Alpaca for prices and options.


1. The quarterly series actually used

All figures $m. S&M and G&A are from the filed income statement, not from Alpha Vantage — see defect 2.

Period Revenue Gross profit GM% S&M R&D G&A GAAP EBIT OM%
2026-06-30 3,987 2,818 70.7% 1,372 915 369 162 4.1%
2026-03-31 3,770 2,830 75.1% 1,216 823 288 503 13.3%
2025-12-31 3,568 2,734 76.6% 1,150 773 368 443 12.4%
2025-09-30 3,407 2,633 77.3% 1,056 750 255 572 16.8%
TTM 14,732 11,015 74.77% 4,794 3,261 1,280 1,680 11.40%
2025-06-30 3,215 2,491 77.5% 1,128 734 271 358 11.1%
2025-03-31 3,088 2,437 78.9% 703 229 451 14.6%
2024-12-31 2,957 2,326 78.7% 773* 374 12.6%
2024-09-30 2,797 2,213 79.1% 418 14.9%
Prior TTM 12,057 1,601 13.28%

* Not used; S&M for the prior-year TTM was not reconstructed inside the time box.

Verified against the filing line by line for Q2 2026: subscription revenue $3,877m, professional services $110m, total cost of revenues $1,169m (subscription $1,030m, services $139m), gross profit $2,818m, S&M $1,372m, R&D $915m, G&A $369m, total operating expenses $2,656m, income from operations $162m, interest income $70m, other income (expense) net +$206m, income before taxes $438m, tax $140m, net income $298m, basic EPS $0.29. Every figure ties.

TTM is used, not last fiscal year. FY2025 revenue was $13,278m; using it would understate the base by 11.0%.


2. Defects found — Alpha Vantage

DEFECT AV-1 (HIGH, new) — sellingGeneralAndAdministrative carries G&A only

Period AV sellingGeneralAndAdministrative Filed SG&A (S&M + G&A) Error
NOW 2026-06-30 $369m $1,741m (S&M $1,372m + G&A $369m) 4.72x / $1,372m understated
NOW TTM $1,280m $6,074m 4.75x

AV's field is the G&A line alone; the entire sales-and-marketing expense is absent from it. AV's operatingExpenses total is correct ($2,656m, ties to the filing), so grossProfit − operatingExpenses = operatingIncome reconciles and every internal consistency check passes.

Why this is severe. The framework's mandated terminal-margin bridge is m_EBIT,T = m_gross,T − R&D − S&M − G&A − other. Built from AV fields alone it becomes 74.77% − 22.14% − 8.69% = 43.9% — because S&M reads as zero — against the true 74.77% − 32.54% − 22.14% − 8.69% = 11.40%. A 32.5pp error on the exact parameter this project has already broken five times. This is the brief's defect #2 in its purest form: a vendor that is wrong consistently defeats every consistency test. Not in known-silent-failures.md. Reproduced on INTU (4.77x). Recommend adding.

DEFECT AV-2 (HIGH, new) — ebit is not operating income

Period AV ebit Filed income from operations Error
NOW 2026-06-30 $504m $162m 3.11x / $342m overstated
NOW 2026-03-31 $673m $503m 1.34x
NOW 2025-09-30 $700m $572m 1.22x

AV computes ebit = incomeBeforeTax + interestExpense (438 + 66 = 504). On NOW that silently absorbs the +$206m of non-operating "other income (expense), net" — a strategic-investment gain — plus $70m of interest income. Using AV's ebit as the operating-margin numerator gives a Q2 2026 operating margin of 12.6% against the filed 4.1% — an 8.5pp error, and it would have concealed the entire purchase-accounting story.

Same family as the brief's warning about ebitda, but on a different field and larger in relative terms. The brief names ebitda; ebit is equally unsafe and is not currently flagged. Recommend adding.

DEFECT AV-3 (confirmed, as warned) — ebitda unusable

NOW 2026-06-30: AV ebitda $911m. Computed from the cash-flow statement as operating income plus |D&A|: $162m + $407m = $569m. AV's figure is its own (wrong) ebit plus D&A. Never used. The brief's warning holds on two more names.

DEFECT AV-4 (LOW) — share count

AV commonStockSharesOutstanding 1,037m vs the 10-Q's 1,033.862m — 0.3% high. Immaterial, but reported rather than silently adopted. The company's own diluted figure (1.04bn, from the guidance table) is used.

DEFECT AV-5 (HIGH, tooling) — EARNINGS_ESTIMATES returns an empty array

EARNINGS_ESTIMATES for NOW returns {"symbol":"NOW","estimates":[]}. Same for INTU. The premium entitlement's headline feature — built-in 7/30/60/90-day revision history — is unavailable on two names above $90bn of market capitalisation. Consensus Criteria is therefore INDETERMINATE, which per criteria.md blocks nothing. No consensus figure was substituted from another source and none was invented.


3. Defects found — tooling

DEFECT TOOL-1 (MEDIUM) — av_vs_edgar.py reports a rate limit as missing data

sym      cmp  dis   worst   inv  trust
INTU      --   --      --     --   AV_NO_QUARTERLY: Minute-level rate
NOW       --   --      --     --   AV_NO_QUARTERLY: Minute-level rate
  clean: 0/2   failed audit: 0   no EDGAR overlap: 0

The script hit Alpha Vantage's per-minute burst limiter and reported AV_NO_QUARTERLY — "no quarterly data" — rather than "rate limited." AV had 64 quarterly periods for NOW and 81 for INTU; the data was there. It also reported clean: 0/2 · failed audit: 0, which reads as "nothing wrong found" when in fact nothing was checked.

This is calibration item D1 — "existence is not validity" — occurring inside the audit tool built to catch D1. The mandated cross-check was performed by hand instead: every Q2 2026 income-statement line, the balance sheet, the share count and the EPS were verified against the filed 10-Q, and defects AV-1 through AV-4 were found that way. Recommend the script distinguish a rate-limit response from an empty response and retry with backoff.


4. Screen-input validation

Input Screen Verified Assessment
Demonstrated revenue CAGR 22.4% 22.5% (3y TTM), 23.3% (5y TTM) Validated.
Required CAGR 22.8% 35.7% at my terminal margin and an identity-derived 12.5x exit The screen's figure is reproducible only at an exit multiple near 21x. See below.
Margin −0.4pp −13.2pp Direction identical, magnitude 33x wider. The FAIL is real and more robust than the screen suggested.
Valuation verdict FAIL FAIL Confirmed.
Share count / split basis 1,033.862m post-5-for-1 (effective 2025-12-17); Alpaca prices split-adjusted Explicitly checked. The CRWD 4.0x pre-/post-split basis mismatch does NOT recur.
Net cash −$810m Cash $2,503m + ST investments $2,161m + LT marketable securities $2,043m − debt $7,517m. Alternatives disclosed: +$1,263m including strategic investments; −$1,746m treating leases as debt.
TTM revenue $14,732m Four quarterly periods summed. FY2025 alone would be $13,278m, 11.0% low.
Growth trend Reported +24.0%; organic ~21–22% Contaminated by $11.3bn of M&A closing inside the window. Materially smaller than PANW's 16.9pp, so the CAGR survives — but any ACCELERATING label on the reported figure would be wrong.
Operating margin TTM 11.40%, down from 13.28%; latest quarter 4.1% Any screen keyed on GAAP margin change scores NOW as deteriorating. Non-GAAP was flat at 29.4% vs 29.7% and is guided to 31.5%. The difference is entirely purchase accounting.
Gross margin 74.77% TTM, 70.7% latest quarter The 6.8pp YoY drop is ~1.5pp intangible amortisation in cost of revenue and ~2.1pp genuine cloud/AI cost inflation, which management guides as permanent.

Reproducing the screen's −0.4pp. From the sensitivity grid in NOW_Valuation.md, required CAGR 22.6% occurs at a 20.8x exit multiple with a 23.0% terminal margin. The screen's near-miss was produced by an exit multiple 8.4x above what the reinvestment identity EV_T/EBIT_T = (1−t)(1−g/ROIC)/(WACC−g) warrants — not by the terminal margin. That is a different failure mode from the five recorded terminal-margin defects and worth logging as such: the exit multiple, not the terminal margin, was the unexamined parameter on this name.


5. Terminal-margin provenance (required by valuation.md rule 1: assert, never clamp)

Field Value
terminal_margin 0.230
terminal_margin_source own_opex_bridge_plus_company_guidance
Raw trailing value 0.1140 (TTM GAAP), 0.1374 (FY2025), ~0.155 (cleaned of transitory charges)
Transformation Four-line forward opex bridge; no clamp, no percentile, no industry median, no max() applied
Bridge 0.755 gross − 0.270 S&M − 0.190 R&D − 0.065 G&A = 0.230
Constraint m_EBIT,T ≤ m_gross,T 0.230 ≤ 0.755 ✓ (52.5pp headroom)
Relation to own trailing actual +11.6pp above reported TTM; +7.5pp above cleaned. Not below — the recorded defect does not occur.
Non-GAAP cross-check 0.34 non-GAAP − 0.095 SBC − 0.015 amortisation = 0.230; SBC leg is the company's own published commitment ("less than 10% of revenue by 2029", FAD 2026-05-04)
Largest single judgement The SBC leg. At today's 16.4% the terminal margin is ~16.5% and the Valuation Criteria fails wider.
evidence_grade A

6. Items not completed inside the time box, stated rather than estimated